Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

The document concludes that various drugs can manage symptoms and metabolic issues in women with PCOS.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

High androgen levels can cause excessive hair growth and may indicate serious health issues, including heart disease and fertility problems.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

Statins may help treat PCOS by lowering androgen levels and improving cholesterol.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

The research found that measuring androgens in urine can give extra information about body metabolism and is linked to androgen levels in the blood, especially in young girls.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Hirsutism is common body hair growth due to genetics and hormones, and while not a disease, it can be distressing; virilisation includes hirsutism with other male traits and needs medical attention.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Spironolactone can reduce hair growth in women with hirsutism.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Low androgen levels can still cause female pattern hair loss.

Most women with excessive hair growth have PCOS; treatment varies and focuses on preventing new hair, with electrolysis as the only permanent removal method.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Hyperadrenocorticism in ferrets is linked to neutering and indoor housing, and is best treated with surgery and a deslorelin implant.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

Hormonal therapy is a treatment option for acne, the only medical treatment for hirsutism, and the most promising for androgenetic alopecia.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

A new gene, JMJD1C, may affect testosterone levels in men.

Acupuncture may improve reproductive and metabolic functions in PCOS without negative side effects, but more research is needed to confirm its effectiveness.